Hydrochlorothiazide (Esidrix, HydroDiuril, Oretic)
Category:
Description:
Indications:
Contraindications:
-
Anuria
-
Renal
decompensation
Precautions:
-
Pregnancy
category D; 1st trimester may increase risk of congenital
defects; use in later trimesters does not seem to carry this risk
-
Hypokalemia,
renal disease, hepatic disease, gout
-
COPD,
lupus erythematosus, diabetes mellitus
-
Children,
vomiting, diarrhea, hyperlipidemia
Adverse
Reactions (Side Effects):
-
CNS:
depression, dizziness, drowsiness, fatigue, paresthesia, weakness,
headache
-
CV:
irregular pulse, orthostatic hypotension, palpitations, volume
depletion
-
EENT:
blurred vision
-
GI:
anorexia, constipation, cramps, diarrhea, nausea, pancreatitis,
vomiting
-
GU:
frequency, decreased libido, impotence
-
HEME:
agranulocytosis, aplastic anemia, hemolytic anemia, leukopenia,
neutropenia, thrombocytopenia
-
METAB:
hypercalcemia, hyperglycemia, hyperuricemia, hypochloremia,
hypokalemia, hypomagnesemia, hyponatremia, increased creatinine, BUN
-
SKIN:
fever, photosensitivity, purpupa, rash, urticaria
|
Dosage:
Administered
orally (tablet, solution)
-
Adult: PO 12.5-50mg daily, max 200mg daily; doses >50 mg/day
generally not recommended due to increased incidence of hypokalemia
and other metabolic disturbances
-
Child: PO (<6 months) 2-3.3 mg/kg/day in 2 divided doses; (>6
months) 2 mg/kg/day in 2 divided doses
Drug
interactions:
-
Antidiabetics:
thiazide diuretics tend to increase blood glucose, may increase dosage
requirements of antidiabetic drugs
-
Digitalis
glycosides: diuretic-induced hypokalemia may increase risk of
digitalis toxicity
Special
considerations:
|
Home
· Military Medicine
· Sick Call · Basic Exams
· Medical Procedures
· Lab and X-ray · The Pharmacy
· The Library · Equipment
· Patient Transport
· Medical Force
Protection · Operational Safety · Operational
Settings · Special
Operations · Humanitarian
Missions · Instructions/Orders · Other Agencies · Video Gallery
· Forms · Web Links · Acknowledgements
· Help · Feedback Approved for public release;
Distribution is unlimited. The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.
Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations
Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by The Brookside Associates, LLC. It contains
original contents from the official US Navy NAVMED P-5139, but has been
reformatted for web access and includes advertising and links that were not
present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the
Department of the Navy or the Department of Defense. The presence of any
advertising on these pages does not constitute an endorsement of that product or
service by either the US Department of Defense or the Brookside Associates. The
Brookside Associates is a private organization, not affiliated with the United
States Department of Defense.
© 2015, Brookside Associates, LLC. All rights reserved
Other Brookside Products
|
|